ALO-02

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2014-2016
01220142016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Objective. To evaluate the abuse potential of ALO-02, an abuse-deterrent formulation comprising pellets of extended-release… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Review
2017
Review
2017
BACKGROUND The efficacy of ALO-02, an abuse-deterrent formulation containing extended-release oxycodone and sequestered… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2016
2016
BACKGROUND ALO-02, comprising pellets of extended-release oxycodone surrounding sequestered naltrexone, is intended to deter… (More)
Is this relevant?
Review
2016
Review
2016
INTRODUCTION Chronic low back pain (CLBP) is a common and difficult illness to manage. Some individuals with CLBP have pain… (More)
Is this relevant?
2015
2015
BACKGROUND AND OBJECTIVES ALO-02 capsules, intended to deter abuse, contain pellets of extended-release oxycodone hydrochloride… (More)
Is this relevant?
2015
2015
ALO-02 is an abuse-deterrent formulation consisting of capsules filled with pellets of extended-release oxycodone surrounding… (More)
Is this relevant?
2015
2015
The objective of this multicenter, double-blind, placebo-controlled, randomized withdrawal study was to evaluate the efficacy and… (More)
Is this relevant?
2015
2015
WHAT IS KNOWN AND OBJECTIVE ALO-02 is being developed as an abuse-deterrent formulation of extended-release oxycodone… (More)
Is this relevant?
2014
2014
OBJECTIVE To evaluate the long-term safety of oxycodone-hydrochloride and sequestered naltrexone-hydrochloride (ALO-02… (More)
Is this relevant?